Precision Medicine in Cancer Treatment
Keywords:
Ciencias Médicas, Cáncer, Medicina, Tratamiento, GenéticaReferences
Pezo RC, Bedard PL. Definitions: Translational and Personalised Medicine, Biomarker and Pharmacodynamics. En: Tortora G, Sessa C, Scarpa A, Banerjee S. ESMO Handbook of Translational Research. 1st. Lugano: ESMO Press; 2015.p. 1-12.
Johnson TM. Perspective on precision medicine in oncology. Pharmacotherapy. [Internet]. 2017 [citado 23/8/2020]; 37(9):988-989. Disponible en: https://doi.org/10.1002/phar.1975.
Prat A, Pineda E, Adamo B, Galvan P, Fernandez A, Gaba L, et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. [Internet]. 2015 [citado 23/8/2020]; 24(Suppl 2):S26-S35. Disponible en: http://dx.doi.org/10.1016/j.breast.2015.07.008.
Krzyszczyk P, Acevedo A, Davidoff E, Timmins LM, Marrerro Berrios I, Patel M, et al. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). [Internet]. 2018 [citado 23/8/2020]; 6(3-4):79-100. Disponible en: https://doi.org/10.1142/S2339547818300020.
Zhang W, Wang J, Menon S. Advancing cancer drug development through precision medicine and innovative designs. J Biopharm Stat. [Internet]. 2018 [citado 23/8/2020]; 28(2):229-244. Disponible en: https://doi.org/10.1080/10543406.2017.1402784.
White NW, Kulasingam V, Diamandis EP, Yousef GM. Tsongalis GJ, Vermeulen L, et al. The use of targeted therapies for precision medicine in oncology. Clin Chem. [Internet]. 2016 [citado 23/8/2020]; 62(12):1556-1564. Disponible en: https://academic.oup.com/clinchem/article-abstract/62/12/1556/5612042
Mazorra Z, Chao L, Lavastida A, Sanchez B, Ramos M, Iznaga N, et al. Nimotuzumab: beyond the EGFR signaling cascade inhibition. Sem Oncol. [Internet]. 2018 [citado 23/8/2020]; 45(1-2):18-26. Disponible en: https://doi.org/10.1053/j.seminoncol.2018.04.008
Johnson TM. Perspective on precision medicine in oncology. Pharmacotherapy. [Internet]. 2017 [citado 23/8/2020]; 37(9):988-989. Disponible en: https://doi.org/10.1002/phar.1975.
Prat A, Pineda E, Adamo B, Galvan P, Fernandez A, Gaba L, et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. [Internet]. 2015 [citado 23/8/2020]; 24(Suppl 2):S26-S35. Disponible en: http://dx.doi.org/10.1016/j.breast.2015.07.008.
Krzyszczyk P, Acevedo A, Davidoff E, Timmins LM, Marrerro Berrios I, Patel M, et al. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap World Sci). [Internet]. 2018 [citado 23/8/2020]; 6(3-4):79-100. Disponible en: https://doi.org/10.1142/S2339547818300020.
Zhang W, Wang J, Menon S. Advancing cancer drug development through precision medicine and innovative designs. J Biopharm Stat. [Internet]. 2018 [citado 23/8/2020]; 28(2):229-244. Disponible en: https://doi.org/10.1080/10543406.2017.1402784.
White NW, Kulasingam V, Diamandis EP, Yousef GM. Tsongalis GJ, Vermeulen L, et al. The use of targeted therapies for precision medicine in oncology. Clin Chem. [Internet]. 2016 [citado 23/8/2020]; 62(12):1556-1564. Disponible en: https://academic.oup.com/clinchem/article-abstract/62/12/1556/5612042
Mazorra Z, Chao L, Lavastida A, Sanchez B, Ramos M, Iznaga N, et al. Nimotuzumab: beyond the EGFR signaling cascade inhibition. Sem Oncol. [Internet]. 2018 [citado 23/8/2020]; 45(1-2):18-26. Disponible en: https://doi.org/10.1053/j.seminoncol.2018.04.008
Downloads
Published
2021-07-16
How to Cite
1.
Soriano-Lorenzo JL. Precision Medicine in Cancer Treatment. Rev 16 de abril [Internet]. 2021 Jul. 16 [cited 2024 Dec. 12];60(281):e1006. Available from: https://rev16deabril.sld.cu/index.php/16_04/article/view/1006
Issue
Section
Letter to the Editor
License
Those authors who have publications with this journal, accept the following terms:
The authors will retain their copyright and guarantee the journal the right of first publication of your work, which will be under a Creative license Commons Attribution-NonCommercial-ShareAlike 4.0 International . (CC BY-NC-SA 4.0).
The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (eg:deposit it in an institutional telemat
